Mayo Clinic launches neutralizing antibody test to advance
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Mayo Clinic announced that it launched a new SARS-CoV-2 neutralizing antibody test in support of efforts to establish therapies and vaccines for COVID-19.

• Designed the new test to measure the level of neutralizing antibodies against SARS-CoV-2.

• Test provides semi-quantitative detection of total neutralizing antibodies in human serum.

• After infection, most will develop an immune response to COVID-19, including the production of neutralizing antibodies against the SARS-CoV-2 spike glycoprotein.

• However, it’s currently unknown for how long the neutralizing antibodies persist after infection.

• “This new test provides us with incredibly important information about how effective a person’s antibodies are at neutralizing the virus. This will help us identify optimal convalescent plasma donors and ultimately help assess the efficacy of anti-SARS-CoV-2 vaccines.”

Dr. I●●●●●●E G●●●A and 4 others like this2 shares
S●●●●m S●●●●a
S●●●●m S●●●●a Psychiatry
Graet work 👍
Jun 14, 2020Like